RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 125 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93,082 | +10.2% | 86,187 | +31.7% | 0.02% | -20.0% |
| Q2 2023 | $84,445 | +246.5% | 65,461 | +254.6% | 0.02% | +212.5% |
| Q1 2023 | $24,369 | -26.7% | 18,461 | -16.7% | 0.01% | -27.3% |
| Q4 2022 | $33,240 | +269.3% | 22,160 | +177.9% | 0.01% | +83.3% |
| Q2 2022 | $9,000 | -71.0% | 7,975 | -23.6% | 0.01% | -62.5% |
| Q1 2022 | $31,000 | +29.2% | 10,433 | +16.0% | 0.02% | +45.5% |
| Q4 2021 | $24,000 | +71.4% | 8,993 | +125.3% | 0.01% | +22.2% |
| Q3 2021 | $14,000 | +75.0% | 3,992 | +127.9% | 0.01% | +80.0% |
| Q2 2021 | $8,000 | – | 1,752 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |